The chemotherapeutic drug melphalan induces breakage of chromosomes regions rearranged in secondary leukemia
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 37 (1), 65-77
- https://doi.org/10.1016/0165-4608(89)90076-9
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Recommendations for a morphologic, immunologic, and cytogenetic (MIC) working classification of the primary and therapy-related myelodysplastic disordersCancer Genetics and Cytogenetics, 1988
- Cytogenetic analyses in 89 patients with secondary hematologic disorders—Results of a cooperative studyCancer Genetics and Cytogenetics, 1987
- Incidence, previous treatment and chromosome characteristics of secondary acute non-lymphocytic leukemiaCancer Treatment Reviews, 1985
- Chromosome analysis of 63 cases of secondary nonlymphoid blood disorders: A cooperative studyCancer Genetics and Cytogenetics, 1984
- Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant diseaseBlood, 1981
- Therapy-related preleukemic syndromeCancer, 1981
- Localization of γ-rays induced chromatid breaks using a three consecutive staining-techniqueMutation Research, 1978
- Acute Leukemia after Alkylating-Agent Therapy of Ovarian CancerNew England Journal of Medicine, 1977
- Localization of chromatid breaks in Fanconi's anemia, using three consecutive stainsHuman Genetics, 1977
- Acute leukemia as a delayed consequence of cancer chemotherapyCancer, 1976